Dr. Walmik Gaikwad | Conjugate Vaccines | Breakthrough Research Award
Inventprise Inc. Redmond, WA, US | United States
Dr. Walmik Gaikwad is a skilled biotechnologist and manufacturing leader with more than two decades of experience spanning academic research, industrial R&D, and large-scale vaccine production. He holds a Ph.D. in Chemical and Biotechnology from Savitribai Phule Pune University, where his doctoral work focused on developing conjugation processes for Streptococcus pneumoniae capsular polysaccharides with carrier proteins. He earned his M.Tech. in Biotechnology from Padmashree Dr. D. Y. Patil Institute for Biotechnology and Bioinformatics, specializing in bioremediation of phenolic compounds, and his B.Tech. in Chemical–Pharmaceutical and Fine Chemicals from Dr. Babasaheb Ambedkar Marathwada University, where he explored the synthesis of chromenone derivatives. Professionally, Dr. Gaikwad has led projects across upstream, downstream, and conjugation process development with extensive expertise in cGMP and GLP environments. His career includes key roles at Inventprise Inc., Redmond, where he currently manages vaccine manufacturing operations, and the Serum Institute of India, where he contributed significantly to multivalent conjugate vaccine R&D and production, regulatory audits, and technology transfer. His research interests lie in vaccine development, process optimization, and bioprocess scale-up under stringent quality frameworks. Recognized for his strategic leadership, regulatory acumen, and scientific rigor, Dr. Gaikwad continues to advance innovation in global vaccine manufacturing.
Profile: Google Scholar
Featured Publications
Simultaneous purification and depolymerization of Streptococcus pneumoniae serotype 2 capsular polysaccharides by trifluoroacetic acid
Purification of capsular polysaccharides isolated from S. pneumoniae serotype 2 by hydrogen peroxide and endonuclease
Effect of trifluoroacetic acid on the antigenicity of capsular polysaccharides obtained from various Streptococcus pneumoniae serotypes
Partial depolymerization of capsular polysaccharides isolated from Streptococcus pneumoniae serotype 2 by various methods
Methods for simultaneous fragmentation and purification of bacterial polysaccharides
Method for obtaining purified bacterial polysaccharides